Roche (RHHBY)(RHHBF)(RHHVF) said its experimental eye drug vamikibart helped patients maintain improvements in vision for a full year in two late-stage clinical trials, potentially offering an ...
A room with just one bedMy clinic only has two rooms. An examination room and a room with just one bed in it.There are no ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today new one-year data from the Phase III ...
In the MEERKAT and SANDCAT studies, vamikibart demonstrated sustained improvements in vision and reductions in macular ...
Kenneth C. Fan, MD, MBA, shared 4-year REMAIN data showing durable vision gains with MCO-010 in retinitis pigmentosa.
Merck (MRK) said its experimental eye drug remigromig improved vision in patients with a diabetes-related eye disease, meeting the main goal of a late-stage clinical trial. However, patients receiving ...
The Daily Mail ventured out to test some of the most viral and out-of-the-box wedding treatments to see whether the ...
Bryan shifted on the hard plastic chair. The overhead light buzzed steadily. The smell of burnt diesel and scorched plastic ...
Wests Tigers have secured the signature of veteran Newcastle Knights forward Tyson Frizell on a one-year deal for the 2027 ...
Rojas (back) recently received a cortisone injection but was included on the Dodgers ' roster for the NLCS, Alden Gonzalez of ESPN.com reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results